Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension (SNOOPY2)

This study is currently recruiting participants. (see Contacts and Locations)

Verified December 2016 by Assistance Publique - Hôpitaux de Paris

Sponsor:
Assistance Publique - Hôpitaux de Paris

Collaborators:
Technion, Israel Institute of Technology
Bayer

Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

ClinicalTrials.gov Identifier:
NCT02782026

First received: February 23, 2016
Last updated: December 7, 2016

ClinicalTrials.gov processed this record on March 21, 2017

clinicaltrials.gov/ct2/show/NCT02782026

The E-nose clinical trial is the same Technion/Professor Hossam Haick NA-NOSE technology in-licensed by Breathtec Biomedical Inc.

Very Important Note: Bayer AG is a sponsor of the clinical trial.

Bayer, Pharmaceuticals and Chemicals:

2016 Revenues - $50.48 Billion USD
2016 Profit - $4.53 Billion USD
Total Assets - $88.77 Billion USD
Total Equity - $34.43 Billion USD

en.wikipedia.org/wiki/Bayer

All monetary amounts are rounded down conversions from Euros.


/////AMG